blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2952524

EP2952524 - IMMUNOTHERAPY REGIMES DEPENDENT ON APOE STATUS [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  08.07.2022
Database last updated on 31.08.2024
FormerExamination is in progress
Status updated on  28.04.2017
Most recent event   Tooltip08.07.2022Refusal of applicationpublished on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Janssen Sciences Ireland UC
Eastgate Village, Eastgate
Little Island, County Cork / IE
For all designated states
Wyeth LLC
235 East 42nd Street
New York, NY 10017 / US
[2015/50]
Inventor(s)01 / Black, Ronald
2164 Fox Creek Road
Berwyn, PA 19312 / US
02 / Ekman, Lars
213 Avenida Cortez
La Jolla, CA 92037 / US
03 / Lieberburg, Ivan
85 Hillcrest Road
Berkeley, CA 94705 / US
04 / Grundman, Michael
13236 Haxton Place
San Diego, CA 92130 / US
05 / Callaway, James
4893 Drakewood Terrace
San Diego, CA 92130 / US
06 / Gregg, Keith M.
17719 W. Wind Song Avenue
Goodyear, AZ 85338 / US
07 / Jacobsen, Jack Steven
229 Mulberry Road
Apt 6
Ramsey, NJ 07446 / US
08 / Gill, Davinder
20 Charlotte Drive
Andover, MA 01810 / US
09 / Tchistiakova, Lioudmila
3 O'Grady Circle
Stoneham, MA 01810 / US
10 / Widom, Angela
19 Cherokee Road
Acton, MA 01720 / US
 [2015/50]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2015/50]
Application number, filing date15161872.517.10.2008
[2015/50]
Priority number, dateUS20070999423P17.10.2007         Original published format: US 999423 P
US20080083827P25.07.2008         Original published format: US 83827 P
[2015/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2952524
Date:09.12.2015
Language:EN
[2015/50]
Search report(s)(Supplementary) European search report - dispatched on:EP21.10.2015
ClassificationIPC:C07K16/18, A61K39/00, C07K16/28
[2015/50]
CPC:
C07K16/18 (EP,CN,US); A61P25/00 (EP); A61P25/28 (EP);
A61P7/10 (EP); A61P9/00 (EP); C07K16/2896 (EP,US);
G06Q99/00 (EP,US); A61K2039/505 (EP,US); C07K2317/24 (EP,CN,US);
C07K2317/34 (EP,CN,US); C07K2317/56 (EP,CN,US); C07K2317/71 (EP,CN,US);
C07K2317/732 (EP,CN,US); C07K2317/734 (EP,CN,US); C07K2317/77 (EP,CN,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/29]
Former [2015/50]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL09.06.2016
BA09.06.2016
MK09.06.2016
RS09.06.2016
TitleGerman:VOM APOE-STATUS ABHÄNGIGE IMMUNTHERAPIEDOSIERUNGEN[2015/50]
English:IMMUNOTHERAPY REGIMES DEPENDENT ON APOE STATUS[2015/50]
French:RÉGIMES IMMUNOTHÉRAPEUTIQUES DÉPENDANT DU STATUT DE L'APOE[2015/50]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure09.06.2016Amendment by applicant (claims and/or description)
09.06.2016Examination requested  [2016/29]
03.05.2017Despatch of a communication from the examining division (Time limit: M06)
29.09.2017Reply to a communication from the examining division
06.12.2018Cancellation of oral proceeding that was planned for 11.12.2018
11.12.2018Date of oral proceedings (cancelled)
05.02.2019Despatch of communication that the application is refused, reason: substantive examination [2022/32]
30.06.2022Application refused, date of legal effect [2022/32]
Appeal following examination15.04.2019Appeal received No.  T1898/19
12.06.2019Statement of grounds filed
30.06.2022Result of appeal procedure: appeal of the applicant withdrawn
Parent application(s)   TooltipEP08839961.3  / EP2207565
Fees paidRenewal fee
31.03.2015Renewal fee patent year 03
31.03.2015Renewal fee patent year 04
31.03.2015Renewal fee patent year 05
31.03.2015Renewal fee patent year 06
31.03.2015Renewal fee patent year 07
12.10.2015Renewal fee patent year 08
11.10.2016Renewal fee patent year 09
11.10.2017Renewal fee patent year 10
11.10.2018Renewal fee patent year 11
15.10.2019Renewal fee patent year 12
14.10.2020Renewal fee patent year 13
29.09.2021Renewal fee patent year 14
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US5624821  (WINTER GREGORY P [GB], et al) [A] 1-13* claims, in particular claim 4 table 1 *;
 [A]WO2006031653  (WYETH CORP [US], et al) [A] 1-13 * figure 26B; example 5; sequence 88 *;
 [Y]WO2006083689  (NEURALAB LTD, et al) [Y] 1-13 * page 1 - page 2; sequences 1,2 *;
 [XY]US2006280743  (BASI GURIQ [US], et al) [X] 1-6,8-11,13 * examples, in particular example II, VI, VII; tables 7, 9A and 9B; paragraphs [0208], [0215] * [Y] 7,12;
 [Y]  - KINNECOM C ET AL, "Course of cerebral amyloid angiopathy?related inflammation", NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, PHILADELPHIA, US, (20070401), vol. 68, no. 17, doi:10.1212/01.WNL.0000260066.98681.2E, ISSN 0028-3878, pages 1411 - 1416, XP008132668 [Y] 7,12 * paragraph bridging pages 1415-1416, reference 18 *

DOI:   http://dx.doi.org/10.1212/01.wnl.0000260066.98681.2e
 [Y]  - ARGARET M RACKE ET AL, "Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta", JOURNAL OF NEUROSCIENCE, THE SOCIETY, WASHINGTON, DC, US, (20050119), vol. 25, no. 3, doi:10.1523/JNEUROSCI.4337-04.2005, ISSN 1529-2401, pages 629 - 636, XP002660549 [Y] 7,12 * abstract figures *

DOI:   http://dx.doi.org/10.1523/jneurosci.4337-04.2005
 [Y]  - MOUNT CLAIRE ET AL, "Alzheimer disease: progress or profit?", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, (20060701), vol. 12, no. 7, ISSN 1078-8956, pages 780 - 784, XP002620727 [Y] 7,12 * page 784, left-hand column *
 [Y]  - CHALMERS ET AL, "APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.", NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, (20030601), vol. 29, no. 3, ISSN 0305-1846, pages 231 - 238, XP055020648 [Y] 1-13 * page 232, column left * * reference 5 *

DOI:   http://dx.doi.org/10.1046/j.1365-2990.2003.00457.x
by applicantEP0307434
 US4855283
 GB2220211
 EP0367166
 WO9007861
 EP0394827
 WO9014837
 WO9110741
 US5057540
 US5112946
 WO9213069
 WO9312227
 US5225539
 US5336603
 US5349053
 US5359046
 US5447851
 US5530101
 US5545806
 US5569825
 US5585089
 US5612486
 US5622929
 US5625126
 US5624821
 WO9717613
 WO9717614
 US5633425
 US5661016
 US5693762
 US5693761
 US5723125
 WO9823635
 US5770429
 US5783181
 US5789650
 WO9840100
 US5814318
 US5844095
 WO9906536
 US5874299
 US5877397
 US5908626
 WO0142306
 WO0200245
 WO0212553
 US6387674
 WO0246237
 US2002162129
 WO02088306
 WO02088307
 WO02096350
 WO03016467
 US2003068325
 US2003157579
 WO03070760
 US2003165496
 US6624821
 WO03077858
 US2004025363
 US2004038304
 US2004038317
 WO2004016282
 WO2004031400
 WO2004032868
 US2004082762
 US2004087777
 US6750324
 US2004132066
 US2004141984
 WO2004072266
 WO2004080419
 US2004213800
 EP1481008
 US2004241164
 US2004242845
 US2004247612
 WO2004108895
 US2004265308
 US2005008625
 WO2005012330
 WO2005028511
 US2005090648
 US2005118651
 US6906169
 US2005130266
 US2005142131
 WO2005065348
 WO2005069970
 US2005196399
 WO2005081872
 US2005255552
 WO2005123775
 WO2006003291
 WO2006006604
 WO2006005707
 WO2006036291
 US2006073158
 WO2006055778
 WO2006066089
 US2006134098
 US2006160184
 US2006165682
 WO2006081171
 US2006193850
 US2006198851
 WO2006118959
 US7135181
 US2006257396
 WO2006121656
 US2007020685
 US7195761
 US2007081998
 WO2007062088
 US2007134762
 US2007160616
 US2007166311
 WO2007113172
 US2007248606
 US2007281006
 US7318923
 US7320790
 US2008025988
 US7335478
 US7365168
 US2008145373
    - SELKOE, TINS, (1993), vol. 16, page 403
    - SELKOE, J. NEUROPATHOL. EXP. NEUROL., (1994), vol. 53, page 438
    - DUFF ET AL., NATURE, (1995), vol. 373, page 476
    - GAMES ET AL., NATURE, (1995), vol. 373, page 523
    - GOATE ET AL., NATURE, (1991), vol. 349, page 704
    - CHARTIER HARLAN ET AL., NATURE, (1991), vol. 353, page 844
    - MURRELL ET AL., SCIENCE, (1991), vol. 254, page 97
    - MULLAN ET AL., NATURE GENET., (1992), vol. 1, page 345
    - HARDY, TINS, (1997), vol. 20, page 154
    - SONGSIVILAI; LACHMANN, CLIN. EXP. IMMUNOL., (1990), vol. 79, pages 315 - 321
    - KOSTELNY ET AL., J. IMMUNOL., (1992), vol. 148, pages 1547 - 1553
    - Epitope Mapping Protocols in Methods in Molecular Biology, (1996), vol. 66
    - STAHLI ET AL., METHODS IN ENZYMOLOGY, (1983), vol. 9, page 242
    - KIRKLAND ET AL., J. IMMUNOL., (1986), vol. 137, page 3614
    - MOREL ET AL., MOL. IMMUNOL., (1988), vol. 25, no. 1, page 7
    - CHEUNG ET AL., VIROLOGY, (1990), vol. 176, page 546
    - MOLDENHAUER ET AL., SCAND. J. IMMUNOL., (1990), vol. 32, page 77
    - HARDY ET AL., TINS, (1997), vol. 20, pages 155 - 158
    - RAVETCH; KINET, ANNU. REV. IMMUNOL, (1991), vol. 9, pages 457 - 92
    - CAPEL ET AL., IMMUNOMETHODS, (1994), vol. 4, pages 25 - 34
    - DE HAAS ET AL., J. LAB. CLIN. MED., (1995), vol. 126, pages 330 - 41
    - GENOMICS, (1988), vol. 3, pages 373 - 379
    - J. BIOL. CHEM., (1984), vol. 259, pages 5495 - 5499
    - PROC. NATL. ACAD. SCI. U.S.A., (1985), vol. 82, pages 3445 - 3449
    - CORDER, SCIENCE, (1993), vol. 261, pages 921 - 3
    - FARRER, JAMA, (1997), vol. 278, pages 1349 - 56
    - SAUNDERS, NEUROLOGY, (1993), vol. 43, pages 1467 - 72
    - PEDIATRIC NEUROLOGY, vol. 20, no. 3, pages 241 - 243
    - AJNR, vol. 26, pages 825 - 830
    - NEJM, vol. 334, no. 8, pages 494 - 500
    - PEDIATR NEPHROL, vol. 18, pages 1161 - 1166
    - INTERNAL MEDICINE JOURNAL, vol. 35, pages 83 - 90
    - JNNP, vol. 68, pages 790 - 79 1
    - AJNR, vol. 23, pages 1038 - 1048
    - PAKJ MED SCI, vol. 21, no. 2, pages 149 - 154
    - AJNR, vol. 21, pages 1199 - 1209
    - QUEE ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 10029 - 10033
    - NATURE, (1994), vol. 148, pages 1547 - 1553
    - NATURE BIOTECHNOLOGY, (1996), vol. 14, page 826
    - BLECK, BIOPROCESSING JOURNAL, (200509), page 1
    - ASAMI-OD ET AL., NEURODEGENERATIVE DISEASES, (2005), vol. 2, pages 36 - 43
    - RAVETCH; KINET, ANNU. REV. IMMUNOL., (1991), vol. 9, page 457
    - PARREN ET AL., J. IMMUNOL., (1992), vol. 148, page 695
    - J IMMUNOGEN, (1976), vol. 3, pages 357 - 362
    - LOGHEM, MONOGR ALLERGY, (1986), vol. 19, pages 40 - 51
    - CUNNINGHAM ET AL., J. BIOL. CHEM., (1970), vol. 9, page 3161
    - POWILLEIT ET AL., PLOS ONE, (2007), vol. 2, no. 5, page E415
    - ULRICH ET AL., INTERVIROLOGY, (1996), vol. 39, pages 126 - 132
    - LECHNER ET AL., INTERVIROLOGY, (2002), vol. 45, pages 212 - 217
    - KOLETZKI ET AL., J GEN VIR, (1997), vol. 78, pages 2049 - 2053
    - GRIFFITHS ET AL., J VIROL., (1993), vol. 67, no. 6, pages 3191 - 3198
    - ADAMS ET AL., NATURE, (1987), vol. 329, no. 3, pages 68 - 70
    - SEDLIK ET AL., PNAS, (1997), vol. 94, pages 7503 - 7508
    - WATANABE ET AL., J VIROL., (1996), vol. 76, no. 2, pages 767 - 773
    - BALL ET AL., GASTROENTEROLOGY, (1999), vol. 117, pages 40 - 48
    - SINIGAGLIA F. ET AL., NATURE, (1988), vol. 336, pages 778 - 780
    - CHICZ R.M. ET AL., J. EXP. MED., (1993), vol. 178, pages 27 - 47
    - HAMMER J. ET AL., CELL, (1993), vol. 74, pages 197 - 203
    - FALK K. ET AL., IMMUNOGENETICS, (1994), vol. 39, pages 230 - 242
    - SOUTHWOOD S. ET AL., J. IMMUNOLOGY, (1998), vol. 160, pages 3363 - 3373
    - STOUTE ET AL., N. ENGL. J. MED., (1997), vol. 336, pages 86 - 91
    - CHAN ET AL., ADVANCED DRUG DELIVERY REVIEWS, (1998), vol. 32, pages 173 - 186
    - LANGER, SCIENCE, (1990), vol. 249, page 1527
    - HANES, ADVANCED DRUG DELIVERY REVIEWS, (1997), vol. 28, page 97
    - HSIAO ET AL., SCIENCE, (1996), vol. 274, page 99
    - STAUFENBIEL ET AL., PROC. NATL. ACAD. SCI. USA, (1997), vol. 94, pages 13287 - 13292
    - STURCHLER-PIERRAT ET AL., PROC. NATL. ACAD. SCI. USA, (1997), vol. 94, pages 13287 - 13292
    - BORCHELT ET AL., NEURON, (1997), vol. 19, pages 939 - 945
    - RICHARDS ET AL., J. NEUROSCI., (2003), vol. 23, pages 8989 - 9003
    - CHENG, NAT MED., (2004), vol. 10, no. 11, pages 1190 - 2
    - TAKEUCHI ET AL., AMERICAN JOURNAL OF PATHOLOGY, (2000), vol. 157, pages 331 - 339
    - LAFERLA, NEURON, (2003), vol. 39, pages 409 - 421
    - FANSELOW, ANIM. LEARN. BEHAV., (1990), vol. 18, pages 264 - 270
    - WEHNER ET AL., NATURE GENET., (1997), vol. 17, pages 331 - 334
    - CALDARONE ET AL., NATURE GENET., (1997), vol. 17, pages 335 - 337
    - MANSOURI ET AL., INFECT. IMMUN., (1999), vol. 67, page 1461
    - GELINAS ET AL., AM J OCCUP THER, (1999), vol. 53, pages 471 - 81
    - ROSEN ET AL., AM J PSYCHIATRY, (1984), vol. 141, pages 1356 - 64
    - MCKHANN ET AL., NEUROLOGY, (1984), vol. 34, pages 939 - 44
    - FOLSTEIN ET AL., J PSYCH RES, (1975), vol. 12, pages 189 - 198
    - MORRIS, NEUROLOGY, (1993), vol. 43, pages 2412 - 2414
    - ROSEN ET AL., ANN NEUROL., (1980), vol. 17, pages 486 - 488
    - JOHNSON-WOOD ET AL., PROC. NATL. ACAD. SCI., USA, (1997), vol. 94, pages 1550 - 55
    - IDUSOGIE ET AL., J. IMMUNOL., (2000), vol. 164, pages 4178 - 4184
    - PHILLIPS ET AL., CANCER RES., (2000), vol. 60, pages 6977 - 84
    - APRILE ET AL., CLIN. EXP. IMMUNOL., (1981), vol. 46, pages 565 - 76
 WO2005US45614
 WO2007US09499
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.